Sudan and South Sudan Pharmaceuticals & Healthcare Report Q2 2018
Sudan continues to perpetuate a highly challenging environment for multinational drugmakers. While the removal ofrestrictions will improve Sudan's economic growth outlook and relations with the US, the operating environment remains highlychallenging and will continue to restrict company activity. Over the long term, a gradually improving business climate and Sudan'smore favourable position in the International community hold upside risk for pharmaceutical investment; however, the combinedeffects of country- and industry-specific risks are major deterrents for foreign drugmakers.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook